In addition to being faster and less invasive than a traditional tissue biopsy, the blood test is also potentially more accurate.

By designing proteins de novo scientists can more efficiently create novel therapeutics tailored for specific biological ...

PRDX6 and GSTP1 identified as promising enzyme targets for neuroblastoma, offering an alternative to retinoic acid differentiation therapy.

GEN ranks not only the top 10 publicly traded developed of editing-based therapies, but the top five privately held companies ...

A Roots Analysis study showed the market for ADC manufacturing is $1.79 billion today, but is expected to grow to $7 billion ...

Nanoneedle tech could enable disease monitoring in real time, allowing clinicians to take multiple, repeatable tests from the ...

Chrysalis partners with life science clients, from early-stage biofirms to pharmaceutical firms, CROs, and other life science ...

PepGen leverages a graph-based approach to improve the detection of hidden protein variants in a computationally efficient manner.

Novel T cell measurement system by Novoviah Pharmaceuticals demonstrates clinical disease detection and monitoring of celiac disease.

Sarepta halts Elevidys shipments for non-ambulatory DMD patients after a second patient death in three months post gene ...

June 26, 2025, is the 25th anniversary of the White House announcement of the first sequencing of the human genome, and July 28, 2025, marks the 30th anniversary of the publication of the first ...

Koby Baranes, PhD, head of science at Clock Bio, cautions, “Aging is not yet fully understood and existing models often fail ...